Independent factors of reduced glomerular filtration rate in patients with hypertension and associated gender-related clinical conditions

P. 3-7

Authors: L.N. Korichkina O.B. Poselyugina V.N. Borodina

0

4083

Cardiac bridge integrator 1 impact on the structural and functional state of the heart in the post-infarction period

P. 8-11

Authors: M.A. Melnikova V.I. Ruzov R.Kh. Gimaev

0

1262

Matrix metalloproteinases, their inhibitors and inflammatory markers in patients with chronic heart failure

P. 12-17

Authors: E.V. Reznik E.S. Krupnova M.A. Bilinskaya A.A. Yasnovskaya I.G. Nikitin S.N. Perekhodov

0

3592

Inclisiran use in clinical practice in patients with dyslipidemia: first results

P. 18-29

Authors: E.A. Polyakova S.V. Lapin A.V. Mazing A.V. Lisker M.Yu. Sitnikova P.A. Fedotov M.A. Simonenko V.D. Nazarov Yu.Sh. Khalimov

0

7584

Secretoneurin role in cardiovascular diseases

P. 30-34

Authors: A.M. Aliyeva E.V. Reznik N.V. Teplova M.B. Kerimov A.M. Rakhaev B.Z. Balagova E.Z. Etezova L.M. Shnakhova A.G. Koval S.M. Etezova I.A. Kotikova I.G. Nikitin

0

1904

Modern approach to optimizing antiarrhythmic therapy. Possibilities of ethylmethylhydroxypyridine succinate

P. 35-39

Authors: V.P. Mikhin T.A. Nikolenko V.V. Savelyeva M.A. Chernyatina

0

2203

Current experience and new prospects for the use of the antiarrhythmic drug — cavutilide

P. 40-46

Authors: Yu.A. Yuricheva N.Yu. Mironov Kh.M. Dzaurova S.F. Sokolov S.P. Golitsyn V.V. Vlodzyanovskiy M.M. Belyaeva E.B. Maykov D.A. Gagloeva M.A. Zelberg

0

4726